Analysts suggest that Marty McCary's tenure was marked by significant turnover and mass layoffs of veteran agency staff. A Bloomberg analyst noted that McCary was "very good" to those on the "buy side," implying a cozy relationship with pharmaceutical investors. The hosts question why Robert F. Kennedy Jr. has not been more vocal about the resignation.



















